Evidence map›Paper›PMID 39605957›Full record

ArticleFrontiers in chemistry2024

Structural and antimicrobial properties of synthesized gold nanoparticles using biological and chemical approaches.

Hamidreza Kalantari, Raymond J Turner

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Biogenic Synthesis of Gold Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2025
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hamidreza KalantariDepartment of Biological Sciences, Microbial Biochemistry Laboratory, University of Calgary, Calgary, NW, Canada.
Raymond J TurnerDepartment of Biological Sciences, Microbial Biochemistry Laboratory, University of Calgary, Calgary, NW, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores the synthesis and characterization of gold nanoparticles (AuNPs) using green and chemical methods, employing ginger extract and curcumin as reducing agents, in comparison to sodium citrate reduction. The biosynthesized AuNPs synthesized with ginger extract exhibited an average hydrodynamic diameter of 15 and 10 nm for curcumin-conjugated AuNPs, while chemically synthesized AuNPs with sodium citrate displayed an average size of 10 nm. Assessments via Zeta potential measurements revealed negative surface charges across all samples, with the curcumin-conjugated AuNPs showing -36.3 mV, ginger extract-synthesized AuNPs showing -31.7 mV, and chemically produced gold nanoparticles having a surface charge of -40.4 mV. Transmission Electron Microscopy (TEM) confirmed spherical morphologies for the synthesized nanoparticles,and it revealed the presence of biomolecules embedded within the nanoparticles synthesized using biological materials, whereas chemically synthesized AuNPs lacked such features. The FTIR spectra of the biosynthesized AuNPs highlighted the presence of phenolic and aromatic compounds from the ginger extract and curcumin, indicating their role in coating the nanoparticles. Gas chromatography-mass spectrometry (GC-MS) analysis identified gingerol as a key component in the ginger extract, contributing to nanoparticle capping. The antimicrobial efficacy of the AuNPs was evaluated against

Indexed as

antimicrobial activitychemical AuNPs (sodium citrate)curcumin AuNPsginger AuNPsgold nanoparticles (AuNPs)green synthesisnanoparticle characterization

Identifiers

PMID39605957
PMCPMC11598438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.